drugset / Trial / NCT02301416
Qsymia as an Adjunct to Surgical Therapy in the Superobese
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study tests the efficacy of the medication, Qsymia, as an adjunct therapy in superobese individuals planning to undergo weight loss surgery. Individuals taking the medication before and after surgery will be compared to historical controls who had surgery without taking the medication.
Timeline
- Start
- 2014-12
- Primary completion
- 2018-06-27
- Completion
- 2018-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentermine | Small molecule | 7.5 mg | — |
| Subject | Topiramate | Small molecule | 46 mg | — |